Ray Dalio, the world’s top hedge fund manager, is reining in his horns, says John Stepek. Not because of the markets – but because of politics.
The FTSE 100 saw a sharp rise yesterday after the Bank of England cut interest rates to 0.25% and extended its quantitative easing programme. The index closed up 1.6% at 6,740.
America’s S&P 500 index has the feel of a late-stage bull market about it. It could be near the top, says Dominic Frisby. But it could also go much higher.
Investors fret over valuations and geopolitics, but there are bigger forces at work that weigh on prices. CrossBorder Capital’s Michael J Howell explains.
More than $50bn was wiped off the market value of three American tobacco companies after the US Food and Drug Administration said it wants to lower nicotine in cigarettes to non-addictive levels.
Pharma giant AstraZeneca was banking on a key clinical trial for its cancer drugs. It was a flop. What comes next? asks Alice Gråhns.
The end of the long-running bull market in equities is near, says Dominic Frisby. Investors should turn to “late-cycle assets” – mining stocks and emerging markets.
Tobacco stocks have been staggeringly successful in recent decades. But the industry is now facing real competition. Its run could be about to end, says John Stepek.
Venezuela would have much to gain from seeing the back of its president, Nicolás Maduro. Sadly, there’s not much chance of that.
When buying Asian-focused funds for your portfolio, it’s worth investing with managers who take a long-term view, says Max King.
Many asset classes are very expensive right now. But investors remain remarkably complacent. Be on your guard, says John Stepek.
The United States considers the nuclear option of slapping a ban on the importation of Venezuelan oil.